Are life-extending treatments for terminal illnesses a special case? Exploring choices and…

The following two tabs change content below.

Publication date: Available online 16 December 2017 Source:Social Science & Medicine Author(s): Neil McHugh, Job van Exel, Helen Mason, Jon Godwin, Marissa Collins, Cam Donaldson, Rachel Baker Criteria used by the National Institute for Health and Care Excellence (NICE) to assess life-extending, end-of-life (EoL) treatments imply that health gains from such treatments are valued more than other health gains.

This article is from:  

Are life-extending treatments for terminal illnesses a special case? Exploring choices and…